Cullinan Oncology, Inc. (NASDAQ: CGEM) reported Q1 EPS of ($0.75), $0.08 better than the analyst estimate of ($0.83).

For earnings history and earnings-related data on Cullinan Oncology, Inc. (CGEM) click here.